These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38802404)

  • 1. APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
    Zhou Y; Pirmann S; Lauschke VM
    Pharmacogenomics J; 2024 May; 24(3):17. PubMed ID: 38802404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
    Zhou Y; Mkrtchian S; Kumondai M; Hiratsuka M; Lauschke VM
    Pharmacogenomics J; 2019 Apr; 19(2):115-126. PubMed ID: 30206299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variants.
    Pandi MT; Koromina M; Tsafaridis I; Patsilinakos S; Christoforou E; van der Spek PJ; Patrinos GP
    Hum Genomics; 2021 Aug; 15(1):51. PubMed ID: 34372920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating pharmacogenomic sequencing data into drug response predictions-How to interpret variants of unknown significance.
    Tremmel R; Pirmann S; Zhou Y; Lauschke VM
    Br J Clin Pharmacol; 2023 Sep; ():. PubMed ID: 37759374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating rare genetic variants into pharmacogenetic drug response predictions.
    Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
    Hum Genomics; 2018 May; 12(1):26. PubMed ID: 29793534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards more accurate pharmacogenomic variant effect predictions.
    Park Y; Lauschke VM
    Pharmacogenomics; 2023 Nov; 24(16):841-844. PubMed ID: 37846582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
    Russell LE; Schwarz UI
    Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
    Zhou Y; Lauschke VM
    Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing genomic medicine in epilepsy through a gene-customized approach to missense variant interpretation.
    Traynelis J; Silk M; Wang Q; Berkovic SF; Liu L; Ascher DB; Balding DJ; Petrovski S
    Genome Res; 2017 Oct; 27(10):1715-1729. PubMed ID: 28864458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.
    Christian C; Borden BA; Danahey K; Yeo KJ; van Wijk XMR; Ratain MJ; O'Donnell PH
    Clin Pharmacol Ther; 2020 Aug; 108(2):368-376. PubMed ID: 32236960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
    Han SM; Park J; Lee JH; Lee SS; Kim H; Han H; Kim Y; Yi S; Cho JY; Jang IJ; Lee MG
    Clin Pharmacol Ther; 2017 Mar; 101(3):396-405. PubMed ID: 27727443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pharmacogenetic variants from large scale next generation sequencing data in the Saudi population.
    Goljan E; Abouelhoda M; ElKalioby MM; Jabaan A; Alghithi N; Meyer BF; Monies D
    PLoS One; 2022; 17(1):e0263137. PubMed ID: 35089958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.